Seres Share Price

Seres Share Price

NASDAQ: MCRB | Micro Cap | Healthcare
$1.24
-$0.09 (-6.77%) Last updated on 21 Nov, 2026 | 02:29 IST
  • Performance
  • Chart
  • Fundamentals
  • Profit & Loss
  • Balance Sheet
  • Cash Flow
  • Corporate Actions
  • About
  • Price history
  • FAQs

Seres Stock Performance

Open
$1.27
Prev. Close
$1.33
Circuit Range
N/A
Day Range
$1.25 - $1.27
Year Range
$1.25 - $27.81
Volume
1,714
Average Traded
$1.26

Seres Share Price Today

As of 23 November 2026, Seres Therapeutics, Inc.'s share price is $1.24. The stock opened at $1.27, compared to its previous close of $1.33. During today's trading session, Seres Therapeutics, Inc.'s share price traded between $1.25 and $1.27, with an average price of $1.26. Over the past 52 weeks, the stock has recorded a high of $27.81 and a low of $1.25. In terms of performance, Seres Therapeutics, Inc.'s share price has declined by 83.18% over the last six months and is down 93.13% on a year-on-year basis.

Seres Share Price Chart

Line chart of the Seres price trend over the selected period. The price fell overall, ranging from 1.22 to 1.37, ending at 1.24.
$1.25$1.27
L
Show Current Price
H

Seres Stock Fundamentals & Key Indicators

Market Cap
$10.99M
PE Ratio (TTM)
N/A
Dividend Yield
0.00%
EPS (TTM)
$-4.61
Revenue (TTM)
$790.00M
Return On Equity (TTM)
-219.83%
Profit Margin
721.52%
Debt to Equity
0.00
Quarterly Earnings Growth YoY
-6.19%

Seres Quarterly Profit & Loss

All figures in USD

ParticularsDec 2025Mar 2026Jun 2026Sep 2026
Revenue$0.44$0.36$0.74$0.59
Net Profit-$15.34-$19.91$4.58-$16.29
Net Profit Margin-3486.36%-5530.56%618.92%-2761.02%
Income ChangeN/A-29.79%123.00%-455.68%

Seres Annual Profit & Loss

All figures in USD

Particulars2022202320242025
Revenue$0.00$0.00$0.00$0.79
Net Profit-$250.16-$113.72$0.14$5.70
Net Profit MarginN/AN/AN/A721.52%
Income ChangeN/A54.54%100.12%3971.43%

Seres Balance Sheet

All figures in USD Million

Particulars2025202420232022
Non Current Assets88.82101.14183.19154.02
Current Assets49.3838.67175.41194.76
Total Assets138.19139.81358.6348.78
Non Current Liabilities74.6584.8262.29252.41
Current Liabilities19.3241.22141.1685.6
Total Liabilities93.98126.03403.46338.0
Shareholders' Equity44.2213.78-44.8610.78

Seres Cash Flow

Annually

All figures in USD Million

Particulars2025202420232022
Operating1.12-148.61-117.35-228.82
Investing-0.04142.2910.5882.43
Financing13.9-90.3771.71129.6

Corporate Actions

Split
Ex-date: 22 Apr 2025

About Seres

Seres Therapeutics Inc is a clinical-stage biotechnology company focused on the development of live biotherapeutic candidates. Its pipeline includes candidates such as SER-155 and SER-603, aimed at preventing and treating bacterial infections, antimicrobial resistance, and gastrointestinal immune diseases. The company operates as a single reportable segment, mainly developing microbiome-based therapies targeting bacterial infections, antimicrobial resistance, and gastrointestinal immune diseases.

Seres Historical Returns

Share price history by day, with open and close prices and the day's change
MonthOpenCloseChange %
Nov 2026
$1.87
$1.25
-28.98%
Oct 2026
$3.19
$1.76
-47.77%
Sep 2026
$4.96
$3.37
-32.33%
Aug 2026
$4.97
$4.98
+5.06%
Jul 2026
$7.76
$4.74
-39.85%
Jun 2026
$7.39
$7.88
+6.92%
May 2026
$7.45
$7.37
-0.81%
Apr 2026
$9.20
$7.43
-16.52%
Mar 2026
$8.89
$8.90
+1.71%
Feb 2026
$15.00
$8.75
-40.58%
Jan 2026
$14.99
$14.72
-0.77%
Dec 2025
$18.05
$14.84
-17.74%

Seres Share Price FAQs